Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation

References

• Marina NM, Flynn PM, Rivera GK, Hughes WT. Candida tropicalis and Candida albicans fungemia in children with leukemia. Cancer 1991; 68: 594–599
   PubMed Web of Science ®Google Scholar
• Marshall JC, Christou NV, Horn R, Meakins JL. The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 1988; 123: 309–315
   PubMedGoogle Scholar
• Miro, JM, Brancos, MA, Abello, R, et al. Costochondral involvement in systemic candidiasis in heroin addicts: clinical, scintigraphic, and histologic features in 26 patients. Arthritis Rheumat 1988; 31: 793–797
   PubMed Web of Science ®Google Scholar
• Mora, NP, Cofer, JB, Solomon, H, et al. Analysis of severe infections after 180 consecutive liver transplants: The impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. Transplant Proc 1991; 23: 1528–1530
   PubMed Web of Science ®Google Scholar
• Schneiderman J, Bass A, Morag B. Cryptogenic Candida albicans cholecystitis. Br J Surg 1987; 74: 649–649
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Flohr A, Simmons RL. Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. Ann Surg 1982; 195: 177–185
   PubMed Web of Science ®Google Scholar
• Vaudry WL, Tierney AJ, Wenman WM. Investigation of a cluster of Candida albicans infections in a neonatal intensive care unit. J Infect Dis 1988; 158: 1375–1379
   PubMed Web of Science ®Google Scholar
• Whelan WL, Kirsch DR, Kwon-Chung KJ, Wahl SM, Smith PD. Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel or hypervirulent strain. J Infect Dis 1990; 162: 513–518
   PubMed Web of Science ®Google Scholar
• Hospenthal D, Gretzinger K, Rogers A. Treatment of a murine model of systemic candidiasis with liposomal amphotericin B bearing antibody to Candida albicans. J Med Microbiol 1989; 30: 193–197
   PubMed Web of Science ®Google Scholar
• Redmond HP, Shou J, Kelly CJ, Leon P, Daly JM. Protein-calorie malnutrition impairs host defence against Candida albicans. J Surg Res 1991; 50: 552–559
   PubMed Web of Science ®Google Scholar
• Bayer AS, Edwards JE, Guze LB. Experimental intraabdominal candidiasis: Macroscopic, microscopic and cultural natural history. Digestion 1980; 20: 365–374
   PubMed Web of Science ®Google Scholar
• Carlson E. Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality. Infect Immun 1982; 38: 921–924
   PubMed Web of Science ®Google Scholar
• Hau T. Bacteria, toxins, and the peritoneum. World J Surg 1990; 14: 167–175
   PubMed Web of Science ®Google Scholar
• Lorber B, Swenson RM. The bacteriology of intra-abdominal infections. Surg Clin N Am 1975; 55: 1349–1354
   PubMed Web of Science ®Google Scholar
• Sawyer RG, Adams RB, Spengler MD, Pruett TL. Pre-exposure of the peritoneum to live bacteria increases later mixed intraabdominal abscess formation and delays mortality. J Infect Dis 1991; 163: 664–667
   PubMed Web of Science ®Google Scholar
• Deitch EA. Bacterial translocation of gut flora. J Trauma 1990; 30(Suppl 12)S184–S189
   PubMedGoogle Scholar
• Bayer AS, Edwards JE, Guze LB. Experimental intra-abdominal candidiasis in rabbits: Therapy with low-total-dose intravenous amphotericin B. Antimicrob Agents Chemother 1981; 19: 179–184
   PubMed Web of Science ®Google Scholar
• Onderdonk AB, Bartlett JG, Louie TJ, Sillivan-Siegler N, Gorbach SL. Microbial synergy in experimental intra-abdominal abscess. Infect Immun 1976; 13: 22–26
   PubMed Web of Science ®Google Scholar
• Nulsen MF, Finlay-Jones JJ, Skinner JM, Mcdonald PJ. Intraabdominal abscess formation in mice: Quantitative studies on bacteria and abscess-potentiating agents. Br J Exp Pathol 1983; 64: 345–353
   PubMedGoogle Scholar
• Rotstein OD, Kao J, Houston K. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model. J Med Microbiol 1989; 29: 269–276
   PubMed Web of Science ®Google Scholar
• Rotstein OD, Pruett TL, Simmons RL. Lethal microbial synergism in intra-abdominal infections: Escherichia coli and Bacteroides fragilis. Arch Surg 1985; 120: 146–151
   PubMedGoogle Scholar
• Carlson E. Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice. Infect Immun 1983; 39: 193–197
   PubMed Web of Science ®Google Scholar
• Carlson E. Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect Immun 1983; 42: 285–292
   PubMed Web of Science ®Google Scholar
• Carlson E, Johnson G. Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice. Infect Immun 1985; 50: 655–659
   PubMed Web of Science ®Google Scholar